Real world experience of fingolimod after switching multiple sclerosis (MS) therapy; focus on natalizumab naive and experienced persons with MS, respectively

Forsberg, L (author)

Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.

Johansson, S (author)

Karolinska Institutet,Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.

Frisell, T (author)

Karolinska Inst, Dept Med, Stockholm, Sweden.

show more...

Hillert, J (author)

Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.

Nilsson, P (author)

Lund Univ, Dept Clin Sci, Neurol, Lund, Sweden.

Dahle, C (author)

Linkoping Univ, Dept Clin & Expt Med, Linkoping, Sweden.

Sveningsson, A (author)

Danderyd Hosp, Dept Clin Sci, Stockholm, Sweden.

Lycke, J (author)

Univ Gothenburg, Dept Clin Neurosci & Rehabil, Gothenburg, Sweden.

Landtblom, A-M (author)

Uppsala universitet,Neurologi

Burman, Joachim, 1974- (author)

Uppsala universitet,Klinisk immunologi

Walentin, F (author)

Orebro Univ Hosp, Orebro, Sweden.

Martin, C (author)

Danderyd Hosp, Dept Clin Sci, Stockholm, Sweden.

Piehl, F (author)

Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.

Olsson, T (author)

Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden.

show less...

Karolinska Institutet Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden (creator_code:org_t)

SAGE PUBLICATIONS LTD, 2016

2016

English.

In: MULTIPLE SCLEROSIS JOURNAL. - : SAGE PUBLICATIONS LTD. - 1352-4585 .- 1477-0970. ; 22, s. 647-648

Related links:

http://kipublication...

show more...

https://urn.kb.se/re...

show less...

• Conference paper (other academic/artistic)